Literature DB >> 16008535

Relevance of immunological variables in neuroborreliosis and multiple sclerosis.

J Bednárová1, P Stourac, P Adam.   

Abstract

OBJECTIVES: The aims were to investigate the frequency of intrathecal synthesis of specific antibodies against measles (M), rubella (R) and varicella zoster (Z) viruses (MRZ reaction) as a diagnostic marker between multiple sclerosis (MS) and neuroborreliosis (NB) groups and to postulate the most typical cerebrospinal fluid (CSF) variables profile of these entities.
METHODS: Three cohorts of patients were investigated: MS (n = 42), NB (n = 27) and other neurological diseases (OND) (n = 15). Measles, rubella, varicella zoster and borrelia-specific IgG antibodies were measured by ELISA, Q(alb) (CSF/serum albumin ratio) as a marker of blood-CSF barrier function and specific antibody indices (AI) were calculated according to relevant formulae. IgG oligoclonal bands (OB) were detected by isoelectric focusing and immunoenzymatic staining.
RESULTS: Eighty-eight percent of MS patients had positive MRZ reaction and 26.2% had positive anti-borrelia AI. Eighty-nine percent of NB patients had positive anti-borrelia AI and two patients had individually anti-measles and rubella positive AI. MS-CSF variables profile included the presence of IgG OB in 81%, elevated Q(alb) in 31% and normal cell count in 66.7%. Of NB patients IgG OB were positive in 74%, elevated Q(alb) in 81.5% and normal cell count in 7.4%.
CONCLUSION: MRZ reaction was proved as statistically significant marker in differential diagnosis between MS and NB. Typical CSF variables profile of these two entities is highly supportive, especially when MRZ is included.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008535     DOI: 10.1111/j.1600-0404.2005.00418.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

1.  Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system.

Authors:  J Svatonová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 2.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

3.  The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Authors:  Tilman Hottenrott; Elisabeth Schorb; Kristina Fritsch; Rick Dersch; Benjamin Berger; Daniela Huzly; Sebastian Rauer; Ludger Tebartz van Elst; Dominique Endres; Oliver Stich
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

Review 4.  Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.

Authors:  Klemens Ruprecht; Brigitte Wildemann; Sven Jarius
Journal:  J Neurol       Date:  2017-11-02       Impact factor: 4.849

5.  Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs' heterochromic cyclitis.

Authors:  Peter C Ruokonen; Sylvia Metzner; Aylin Ucer; Necip Torun; Jörg Hofmann; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04       Impact factor: 3.117

Review 6.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

7.  A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.

Authors:  Cecilia Ahlgren; Kjell Torén; Anders Odén; Oluf Andersen
Journal:  Eur J Epidemiol       Date:  2009-07-26       Impact factor: 8.082

8.  Cerebrospinal fluid and serum prealbumin (transthyretin) in patients with multiple sclerosis (MS): comparison of particular subgroups of MS patients.

Authors:  M Hybelová; J Svatonová; O Sobek; P Adam; D Dolezil; D Adam
Journal:  Folia Microbiol (Praha)       Date:  2009-05-06       Impact factor: 2.099

9.  The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.

Authors:  Tilman Hottenrott; Rick Dersch; Benjamin Berger; Sebastian Rauer; Matthias Eckenweiler; Daniela Huzly; Oliver Stich
Journal:  Fluids Barriers CNS       Date:  2015-12-13

10.  Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.

Authors:  Isabel Brecht; Benedikt Weissbrich; Julia Braun; Klaus Viktor Toyka; Andreas Weishaupt; Mathias Buttmann
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.